ESTIMATED SAVINGS IN MEDICAL COSTS WHEN NEW ORAL ANTICOAGULANTS ARE USED FOR THE TREATMENT OF PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION AND VENOUS THROMBOEMBOLISM VS. WARFARIN IN THE U.S

被引：1

作者：

Amin, A. ^{[1
]}

Bruno, A. ^{[2
]}

Trocio, J. ^{[3
]}

Lin, J. ^{[4
]}

Lingohr-Smith, M. ^{[4
]}

机构：

[1] Univ Calif Irvine, Irvine, CA USA

[2] Bristol Myers Squibb Co, Plainsboro, NJ USA

[3] Pfizer, New York, NY USA

[4] Novosys Hlth, Green Brook, NJ USA

来源：

VALUE IN HEALTH | 2015年 / 18卷 / 03期

关键词：

D O I：

10.1016/j.jval.2015.03.802

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

PCV49

引用

页码：A138 / A138

页数：1

共 50 条

[1] Comparison of Medical Costs Avoided When New Oral Anticoagulants Are Used for the Treatment of Patients with Atrial Fibrillation and Venous Thromboembolism in the U.S
Amin, Alpesh N.
Bruno, Amanda
Trocio, Jeffrey
Lin, Jay
Lingohr-Smith, Melissa
BLOOD, 2014, 124 (21)
[2] Estimate of Real-World Medical Costs Avoidance When New Oral Anticoagulants Are Used Vs. Standard Therapy for the Treatment of Patients with Venous Thromboembolism in the U.S
Amin, Alpesh N.
Bruno, Amanda
Trocio, Jeffrey
Lin, Jay
Lingohr-Smith, Melissa
BLOOD, 2014, 124 (21)
[3] Comparison of differences in medical costs when new oral anticoagulants are used for the treatment of patients with non-valvular atrial fibrillation and venous thromboembolism vs warfarin or placebo in the US
Amin, Alpesh
Bruno, Amanda
Trocio, Jeffrey
Lin, Jay
Lingohr-Smith, Melissa
JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (06) : 399 - 409
[4] Oral anticoagulants vs. Warfarin in Patients with Atrial Fibrillation Comment
Diener, H. C.
AKTUELLE NEUROLOGIE, 2014, 41 (05) : E59 - E59
[5] Medical Costs of Oral Anticoagulants vs Warfarin for Atrial Fibrillation Patients with Different Stroke Risks
Deitelzweig S.
Amin A.
Jing Y.
Makenbaeva D.
Wiederkehr D.
Lin J.
Graham J.
Cardiology and Therapy, 2013, 2 (2) : 165 - 170
[6] Out-of-pocket costs for direct oral anticoagulants and prescription abandonment among patients with nonvalvular atrial fibrillation or venous thromboembolism
Zhdanava, Maryia
Ashton, Veronica
Korsiak, Jill
Jiang, Fengyi
Pilon, Dominic
Alberts, Mark
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2025, 31 (04): : 366 - 376
[7] Comparative Effectiveness of Warfarin and New Oral Anticoagulants for the Management of Atrial Fibrillation and Venous Thromboembolism A Systematic Review
Adam, Soheir S.
McDuffie, Jennifer R.
Ortel, Thomas L.
Williams, John W., Jr.
ANNALS OF INTERNAL MEDICINE, 2012, 157 (11) : 796 - +
[8] Risk of major bleeding and thromboembolism in Asian patients with nonvalvular atrial fibrillation using direct oral anticoagulants versus warfarin
Ya-Ling Huang
Ching-Yao Chen
Ching-Chi Chu
International Journal of Clinical Pharmacy, 2022, 44 : 34 - 43
[9] Risk of major bleeding and thromboembolism in Asian patients with nonvalvular atrial fibrillation using direct oral anticoagulants versus warfarin
Huang, Ya-Ling
Chen, Ching-Yao
Chu, Ching-Chi
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (01) : 34 - 43
[10] Evaluation of Medical Costs Avoided When New Oral Anticoagulants Are Used for Extended Treatment of Venous Thromboembolism Based on Clinical Trial Results
Almin, Alpesh
Jing, Yonghua
Trocio, Jeffrey
Lin, Jay
Smith, Melissa Lingohr
Graham, John
CIRCULATION, 2014, 130

← 1 2 3 4 5 →